AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 288: R354-R355, 2005; doi:10.1152/ajpregu.00726.2004
0363-6119/05 $8.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navarro, A.
Right arrow Articles by Boveris, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarro, A.
Right arrow Articles by Boveris, A.

EDITORIAL FOCUS

Hypoxia exacerbates macrophage mitochondrial damage in endotoxic shock

Ana Navarro1 and Alberto Boveris2

1Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Cádiz, Cádiz, Spain; and 2Laboratory of Free Radical Biology, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina

SEPSIS AND SEPTIC SHOCK are major causes of death after trauma and a persistent problem in surgical patients. The prevalent hypothesis regarding the mechanism of sepsis and septic shock is that the syndrome is caused by an excessive defensive and inflammatory response with massive increases of NO and inflammatory cytokines in body fluids, systemic damage to vascular endothelium, and impaired tissue and whole body respiration despite adequate O2 supply. Human muscle biopsies from shock patients show, in correlation with the clinical severity of the case, NO overproduction, glutathione depletion, and mitochondrial respiratory dysfunction with decreased ATP levels and O2 consumption, the latter especially with NAD-linked and complex I-dependent substrates (3, 4, 16). The selective mitochondrial damage associated with sepsis and septic shock has been widely observed and reproduced in experimental animal models (3, 5). However, the prevalent hypothesis described above does not provide a complete description of the series of phenomena in the different cells due to the multiple cell types and organs involved in sepsis and septic shock.

The paper "Hypoxia accelerates nitric oxide-dependent dysfunction of mitochondrial complex I in activated macrophages" by Frost et al. (12) in this issue of the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology focuses on activated macrophages and describes a decreased complex I activity and whole cell respiration and the enhancing effect of reduced O2 concentrations. The paper reports that LPS/IFN-{gamma}-activated macrophages show a very marked increase (~30 times) of the primary NO production and a marked increase (~7 times) of the NO metabolites, peroxynitrite and nitrite.

Macrophage respiration was significantly decreased after cell activation with LPS/IFN-{gamma}, and the effect was partially prevented by GSH and markedly inhibited by a nitric oxide synthase (NOS) competitive inhibitor (L-N5-1-iminoethyl-ornithine; L-NIO). The inhibitory effect of LPS/IFN-{gamma} activation on respiration and on complex I activity increased over time and was accelerated by a low-O2 environment, despite less NO and peroxynitrite being generated. The study by Frost et al. (12) shows an elegant linear correlation between macrophage O2 uptake and complex I activity at four time points and two O2 conditions in the 0- to 24-h period. The direct relationship found between cellular O2 uptake and complex I activity emphasizes the importance of NADH-ubiquinone reductase as a rate-limiting component of mitochondrial respiration in pathological states. Indeed, complex I-decreased activities have been recognized in hereditary and acquired mitochondrial diseases (such as Parkinson’s disease) (7) and in normal senescence (14, 15). The decreased NADH-dehydrogenase activity present in dysfunctional mitochondria generates more reactive oxygen species, primarily superoxide radical by autoxidation of the FMN semiquinone. It was suggested that the oxidative damage produced by free radical reactions is a cause of mitochondrial dysfunction in aging (14, 15).

Frost et al. (12) clearly identified inducible NOS (iNOS) as the upregulated NOS isoform by Western blot. Recently, Alvarez and Boveris (1) reported that diaphragm and heart of LPS-treated rats show a selectively (1.3 to 2.2 times) increased mitochondrial NOS (mtNOS) activity with a lower effect (1.5 to 1.1 times) in the cytosolic NOS. Considering the uncertainty in the specificity of mtNOS antibody reactivity (13), it is possible that macrophage mitochondria increase their mtNOS activity and that the vicinity of NO source and target favor complex I inactivation.

The study by Frost et al. (12) reports an increase in whole cell tyrosine nitration that was inhibited by the NOS inhibitor L-NIO, which was higher when cells were incubated at 21 % O2 compared with 1% O2 and that seems to contribute to the mechanism of complex I and whole cell respiration inhibitions. Nitration was initially higher in mitochondria than in the cytosol, although by 24 h, nitration level was higher in the cytosol. The early mitochondrial nitration agrees with the reported nitration of submitochondrial fractions by the activity of mtNOS (11).

NO has three target sites at the mitochondrial respiratory chain in which NO, directly or indirectly after peroxynitrite formation, inhibits electron transfer. The three sites are NADH-dehydrogenase (complex I), ubiquinone-cytochrome c reductase (complex III), and cytochrome oxidase (complex IV). Cytochrome oxidase (6, 9) and ubiquinol-cytochrome c reductase (17) are directly inhibited by NO. Peroxynitrite, the product of NO and superoxide radical, inhibits in a close-to-irreversible manner both complex III (8) and complex I (10, 18) activities. The study by Frost et al. (12) describes in detail and correlates complex I inhibition with respiratory inhibition in activated macrophages.

Interestingly, NO is the first molecule that fulfills the requirement for a physiological modulator of cytochrome oxidase activity with an O2-competitive mode of binding and inhibition. NO is intramitochondrially produced by mtNOS at a significant rate near the target site, and it has been calculated that endogenous mtNOS activity inhibits mitochondrial respiration in the tissues by 18–25% (2). Cytochrome oxidase inhibition should be even more important in tissues or conditions with low O2 level, such as in inflammation areas. It is then clear that hypoxia enhances both peroxynitrite-dependent complex I inactivation and the reversible and NO/O2-competitive inhibition of complex IV. The reversible cytochrome oxidase inhibition by NO was not observed in the conditions in which macrophage respiration was determined in the study by Frost et al. (12); the respiration assay included a cell dilution in the reaction medium, with the corresponding increase in O2 concentration and decrease in the NO/O2 ratio, before the measurement with the O2-sensitive electrode. The conditions used were particularly convenient to detect the decrease in complex I activity, the main point of entry of reducing equivalents to the mitochondrial respiratory chain, and its relationship to whole macrophage respiration.

FOOTNOTES


Address for reprint requests and other correspondence: A. Navarro, Dept. of Biochemistry and Molecular Biology, Faculty of Medicine, Univ. of Cádiz, P. Fragela 9, 11003 Cádiz, Spain (E-mail: ana.navarro{at}uca.es)

REFERENCES

  1. Alvarez S and Boveris A. Mitochondrial nitric oxide metabolism in rat muscle during endotoxemia. Free Radic Biol Med 37: 1472–1478, 2004.[CrossRef][Web of Science][Medline]
  2. Alvarez S, Valdez LB, Zaobornyj T, and Boveris A. Oxygen dependence of mitochondrial nitric oxide synthase activity. Biochem Biophys Res Commun 305: 771–775, 2003.[CrossRef][Web of Science][Medline]
  3. Boveris A, Alvarez S, and Navarro A. The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic Biol Med 33: 1186–1193, 2002.[CrossRef][Web of Science][Medline]
  4. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, and Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360: 219–223, 2002.[CrossRef][Web of Science][Medline]
  5. Brealey D, Karyampudi S, Jacques TS, Novelli M, Stidwill R, Taylor V, Smolenski RT, and Singer M. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 286: R491–R497, 2004.[Abstract/Free Full Text]
  6. Brown GC and Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295–298, 1994.[CrossRef][Web of Science][Medline]
  7. Carreras MC, Franco MC, Peralta JG, and Poderoso JJ. Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Mol Aspects Med 25: 125–139, 2004.[CrossRef][Medline]
  8. Cassina A and Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328: 309–316, 1996.[CrossRef][Web of Science][Medline]
  9. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, and Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 345: 50–54, 1994.[CrossRef][Web of Science][Medline]
  10. Clementi E, Brown GC, Feelisch M, and Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95: 7631–7636, 1998.[Abstract/Free Full Text]
  11. Elfering SL, Haynes VL, Traaseth NJ, Ettl A, and Giulivi C. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol 286: H22–H29, 2004.[Abstract/Free Full Text]
  12. Frost MT, Wang Q, Moncada S, and Singer M. Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regul Integr Comp Physiol 288: R394–R400, 2005.[Abstract/Free Full Text]
  13. Lacza Z, Snipes JA, Zhang J, Horvath EM, Figueroa JP, Szabo C, and Busija DW. Mitochondrial nitric oxide synthase is not eNOS, nNOS or iNOS. Free Radic Biol Med 35: 1217–1228, 2003.[CrossRef][Web of Science][Medline]
  14. Navarro A. Mitochondrial enzyme activities as biochemical markers of aging. Mol Aspects Med 25: 37–48, 2004.[CrossRef][Medline]
  15. Navarro A and Boveris A. Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am J Physiol Regul Integr Comp Physiol 287: R1244–R1249, 2004.[Abstract/Free Full Text]
  16. Poderoso JJ, Boveris A, Jorge MA, Gherardi CR, Caprile AW, Turrens J, and Stoppani AO. Mitochondrial function in septic shock. Medicina (B Aires) 38: 371–377, 1978.
  17. Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, and Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 328: 85–92, 1996.[CrossRef][Web of Science][Medline]
  18. Riobo NA, Clementi E, Melani M, Boveris A, Cadenas E, Moncada S, and Poderoso JJ. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem J 359: 139–145, 2001.[CrossRef][Web of Science][Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navarro, A.
Right arrow Articles by Boveris, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarro, A.
Right arrow Articles by Boveris, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.